Tivic Health Systems, Inc. (TIVC) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to TIVIC Health System's Third Quarter 2025 Financial Results and Operational Update Conference Call. This call has been pre-recorded. This call is being webcast and the replay will be available on the IR section of the company's website for three months. Before we begin, let me remind you that during today's call, management will make various forward-looking statements. Investors are cautioned that these forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those indicated in our forward-looking statements. Please read the safe harbor statement contained in the press release that Civic Health issued today as well as the risk factors contained in TIVIC Health's filings with the SEC, including its annual report on Form 10-K of the year ended December 31, 2024, and the Form 10-Q to be filed with the SEC today, as well as other companies' SEC filings. Hosting today's call is Jennifer Ernst, TIVIC's CEO, and Lisa Wolfe, TIVIC's CFO. Now let me turn the call over to Jennifer Ernst. Thank you, and welcome to everyone listening today. I'm pleased to be reporting on the progress we have made during the third quarter in building a new TIVIC. As many of you know, at the start of the year, we undertook a significant strategic transformation of TIVIC. Beginning in February, with the licensing of Intolamod and related assets, we expanded from bioelectronics to biologic pharmaceuticals with a common focus on the immune system. and the ways we can harness the immune system to improve clinical outcomes and save lives. We've accomplished a great deal in a very short time. In Q2, we built out the team and secured the first meetings with potential customers fo...